4.3 Article

Adherence: The Goal to Control Asthma

Journal

CLINICS IN CHEST MEDICINE
Volume 33, Issue 3, Pages 405-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ccm.2012.06.002

Keywords

Adherence; Compliance; Asthma control

Funding

  1. 3M
  2. AstraZeneca
  3. GlaxoSmithKline
  4. Merck
  5. Novartis
  6. GSK
  7. Schering
  8. Altair
  9. Asmacure
  10. Boehringer-Ingelheim
  11. Genentech
  12. Pharmaxis
  13. Wyeth
  14. Merck Frosst
  15. MSD
  16. Nycomed
  17. Pharmaceutical Society of Australia

Ask authors/readers for more resources

Asthma management requires adequate adherence to many recommendations, including therapy, monitoring of asthma control, avoidance of environmental triggers, and attending follow-up appointments. Poor adherence is common in patients with asthma and is often associated with increased health care use, morbidity, and mortality. Many determinants of poor adherence have been identified and should be addressed, but there is no clear profile of the nonadherent patient. Interventions to improve adherence therefore demand tailoring to the individual by including patient-specific education, addressing patient fears and misconceptions, monitoring adherence, and developing a shared decision process.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available